Accessibility Statement
Accessibility Statement for U.S. Drug & Device Register
U.S. Drug & Device Register is committed to ensuring digital accessibility for all users, including individuals with disabilities. We believe everyone should be able to access information and services with dignity, independence, and ease.
This statement may be updated periodically to reflect ongoing accessibility improvements and changes to applicable standards.
Last Updated: September 30, 2026
Commitment to Accessibility
We are actively working to improve the accessibility and usability of our website and strive to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA. These guidelines help make web content more accessible for people with a wide range of abilities and disabilities.
Accessibility Features
To support an accessible online experience, we make reasonable efforts to:
-
Provide clear and consistent website navigation.
-
Use descriptive headings and page structure to improve readability.
-
Support keyboard navigation where technically feasible.
-
Maintain adequate color contrast for text and user interface elements.
-
Provide alternative text for meaningful images when appropriate.
-
Design content to be responsive and usable across various devices and screen sizes.
-
Continually review website content and functionality for accessibility improvements.
Ongoing Improvements
Accessibility is an ongoing effort. We regularly evaluate our website and work to identify, prioritize, and address accessibility barriers. As technology evolves, we remain committed to improving the accessibility of our digital services.
Third-Party Content
Some areas of our website may contain links to or content provided by third-party services. While we strive to work with providers that support accessibility, we cannot guarantee the accessibility of third-party content or applications that are not under our direct control.
Requests, issues, and suggestions
If you experience difficulty accessing any part of this website, encounter an accessibility barrier, or require information in an alternative format, we encourage you to contact us.
U.S. Drug & Device Register
Email: accessibility@usdruganddeviceregister.com
Phone: 978-733-7336
When contacting us, please include:
-
The webpage or feature you were attempting to access
-
A description of the issue encountered
-
Your preferred method of communication
We will make reasonable efforts to respond promptly and provide the requested information or assistance.